An update on human interleukin-1: from molecular biology to clinical relevance (Q39832526)

15 September 2017

1 reference

title

An update on human interleukin-1: from molecular biology to clinical relevance (English)

1 reference

15 September 2017

0 references

0 references

C A Dinarello

1

1 reference

15 September 2017

publication date

1 September 1985

1 reference

Journal of Clinical Immunology

15 September 2017

published in

1 reference

15 September 2017

volume

5

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

287-297

1 reference

Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein.

15 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00918247

Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00918247

Fever: The Old and the New

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00918247

Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Molecular basis of fever in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

https://pubmed.ncbi.nlm.nih.gov/3902871

1 reference

12 December 2020

Interleukin 1 activity in normal human urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Identification of a specific interleukin 1 inhibitor in the urine of febrile patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Cleavage of human interleukin 1: isolation of a peptide fragment from plasma of febrile humans and activated monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Regulation of human B-cell activation, proliferation, and differentiation by soluble factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Human leukocytic pyrogen: purification and development of a radioimmunoassay

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Increased plasma interleukin-1 activity in women after ovulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Stimulation of rat mesangial cell proliferation by macrophage interleukin 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Interleukin-1 stimulation of astroglial proliferation after brain injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

A probable endocrine basis for the depression of ketone bodies during infectious or inflammatory state in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Heterogeneity of rabbit endogenous pyrogens is not attributable to glycosylated variants of a single polypeptide chain

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Sleep-promoting effects of endogenous pyrogen (interleukin-1).

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Identification of a membrane-associated interleukin 1 in macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Structural analysis of the charge heterogeneity of human interleukin 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Mechanisms of fever induced by recombinant human interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Cloning and expression of murine interleukin-1 cDNA in Escherichia coli

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Production of intra- and extracellular interleukin-1 (IL-1) by human monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Prostacyclin synthesis induced in vascular cells by interleukin-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Human interleukin 1: purification and properties.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Demonstration of interleukin 1 activity in apparently homogeneous specimens of the pI 5 form of rabbit endogenous pyrogen.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Interleukin 1 and T cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

A pyrogen derived from human white cells which is active in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Infection, inflammation, and interleukin 1 (IL-1)

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Interleukin-1 and the Pathogenesis of the Acute-Phase Response

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

The influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin-1).

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Isolation of an interleukin-1-like factor from human joint effusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases IL-1 production

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Epidermal cytokines: properties of epidermal cell thymocyte-activating factor (ETAF)

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Lymphocyte chemotactic activity of human interleukin 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Demonstration and characterization of two distinct human leukocytic pyrogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Purification of human interleukin 1 from human monocyte culture supernatants and identity of thymocyte comitogenic factor, fibroblast-proliferation factor, acute-phase protein-inducing factor, and endogenous pyrogen

1 reference

https://pubmed.ncbi.nlm.nih.gov/3902871

12 December 2020

Identifiers

DOI

10.1007/BF00918247

1 reference

15 September 2017

1 reference